Journal List > J Korean Ophthalmol Soc > v.49(4) > 1008228

Choi, Lee, and Kim: Gamma Knife Radiosurgery for Orbital Lesions

Abstract

Purpose

To evaluate the effectiveness and safety of treating orbital lesions with gamma knife radiosurgery (GKS).

Methods

Between April 2004 and January 2006, ten patients who had orbital tumors or vascular lesions and who underwent GKS were included in this retrospective study.

Results

Ten patients with orbital lesions were treated with GKS. The group of orbital lesions consisted of 5 meningiomas, 2 schwannomas, 1 cavernous hemangioma, 1 arteriovenous fistula, and 1 adenoidcystic carcinoma of the lacrimal gland. The most common symptom was proptosis. The tumors were located at the orbital apex in eight patients, and five of these patients were treated with fractionated stereotactic radiosurgery. The mean cumulative marginal dose was 17.0 Gy (12-20 Gy), and the mean cumulative maximal dose was 30.8 Gy (16.2–40.4 Gy). The follow-up period ranged from 3 to 25 months (mean 13.9 months). During the follow-up period, magnetic resonance imaging revealed a decrease of tumor volume in 3 patients with symptomatic improvement. In two patients, tumor volume increased. No radiation-induced optic neuropathy, retinopathy, or cataract was observed in any of the 10 patients during the follow-up period.

Conclusions

Gamma knife radiosurgery is an effective and relatively safe treatment when orbital lesions have a high risk of neurosurgical deficits with surgery, when they recur after incomplete resection, or when complete removal of tumor is impossible.

References

1. Maroon JC, Kennerdell JS. Surgical approaches to the orbit. Indications and techniques. J Neurosurg. 1984; 60:1226–35.
2. Lew H, Lee SY, Lee KS, et al. Removal of orbital tumor through transfrontal approach. J Korean Ophthalmol Soc. 1994; 35:1723–7.
3. Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry. 1983; 46:797–803.
crossref
4. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand. 1951; 102:316–9.
5. Pollock BE, Gorman DA, Schomberg PJ, Kline RW. The Mayo Clinic gamma knife experience: indications and initial results. Mayo Clin Proc. 1999; 74:5–13.
crossref
6. Yamamoto M. Gamma Knife radiosurgery: technology, applications, and future directions. Neurosurg Clin N Am. 1999; 10:181–202.
7. Aichholzer M, Bertalanffy A, Dietrich W, et al. Gamma knife radiosurgery of skull base meningiomas. Acta Neurochir (Wien). 2000; 142:647–52.
crossref
8. Chen JC, Giannotta SL, Yu C, et al. Radiosurgical management of benign cavernous sinus tumors: dose profiles and acute complications. Neurosurgery. 2001; 48:1022–30.
crossref
9. Feigl GC, Bonelli CM, Berghold A, Mokry M. Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg. 2002; 97:415–21.
crossref
10. Kobayashi T, Kida Y, Mori Y. Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. J Neurosurg. 2002; 97:422–8.
crossref
11. Pendl G, Schröttner O, Friehs GM, Feichtinger H. Stereotactic radiosurgery of skull base meningiomas. Stereotact Funct Neurosurg. 1995; 64:S11–8.
crossref
12. Sheehan JM, Vance ML, Sheehan JP, et al. Radiosurgery for Cushing's disease after failed transsphenoidal surgery. J Neurosurg. 2000; 93:738–42.
crossref
13. Tishler RB, Loeffler JS, Lunsford LD, et al. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys. 1993; 27:215–21.
crossref
14. Andrews DW, Faroozan R, Yang BP, et al. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery. 2002; 51:890–902.
crossref
15. Chang SD, Adler JR Jr. Treatment of cranial base meningiomas with linear accelerator radiosurgery. Neurosurgery. 1997; 41:1019–25.
crossref
16. Ove R, Kelman S, Amin PP, Chin LS. Preservation of visual fields after peri‐ sellar gamma‐ knife radiosurgery. Int J Cancer. 2000; 90:343–50.
17. Girkin CA, Comey CH, Lunsford LD, et al. Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology. 1997; 104:1634–43.
crossref
18. Leber KA, Bergloff J, Langmann G, et al. Radiation sensitivity of visual and oculomotor pathways. Stereotact Funct Neurosurg. 1995; 64:S233–8.
crossref
19. Movsas B, Movsas TZ, Steinberg SM, Okunieff P. Long-term visual changes following pituitary irradiation. Int J Radiat Oncol Biol Phys. 1995; 33:599–605.
crossref
20. Paek SH, Downes MB, Bednarz G, et al. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys. 2005; 61:795–808.
crossref
21. Estrada J, Boronat M, Mielgo M, et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med. 1997; 336:172–7.
crossref
22. Metellus P, Regis J, Muracciole X, et al. Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery. 2005; 57:873–86.
crossref
23. Brada M, Ford D, Ashley S, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ. 1992; 304:1343–6.
crossref
24. Nelson PB, Goodman ML, Flickenger JC, et al. Endocrine function in patients with large pituitary tumors treated with operative decompression and radiation therapy. Neurosurgery. 1989; 24:398–400.
crossref
25. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A. 2005; 102:13040–5.
crossref
26. Shaw EG, Coffey RJ, Dinapoli RP. Neurotoxicity of Radiosurgery. Semin Radiat Oncol. 1995; 5:235–45.
crossref
27. Hudgins PA, Newman NJ, Dillon WP, Hoffman JC Jr. Radiation-induced optic neuropathy: characteristic appearances on gadolinium-enhanced MR. AJNR Am J Neuroradiol. 1992; 13:235–8.
28. Jiang GL, Tucker SL, Guttenberger R, et al. Radiation-induced injury to the visual pathway. Radiother Oncol. 1994; 30:17–25.
crossref
29. Leber KA, Bergloff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg. 1998; 88:43–50.
crossref

Figure 1.
T1-weighted axial magnetic resonance image (A) and sagittal images (B) before radiosurgery in case 6 with cavernous hemangioma in the left orbital apex. Eighteen months after radiosurgery (C, D) the tumor volume is reduced.
jkos-49-555f1.tif
Figure 2.
Optic nerve sheath meningioma in a 34-year-old woman (case 1) presenting with decreased visual acuity in her left eye for 2 months. Before gamma knife surgery axial T1 contrast MR image (A) reveals a well-circumscribed retrobulbar mass in the left orbit and 7 months after fractionated gamma knife surgery (B) central necrotic lesion is shown. (C) Visual field examination of the left eye before radiosurgery showed extensive field loss. The visual acuity of her left eye decreased to 0.1. (D) Seven months after radiosurgery the visual field improved except small paracentral scotoma and visual acuity improved to 0.7.
jkos-49-555f2.tif
Table 1.
Radiosurgical feature of lesions treated with gamma knife radiosurgery
No. of patients Pathologic diagnosis Location Maximal Dose (Gy) Marginal dose (Gy) No. of fraction
1 Meningioma Optic n. 10.2 5 3
2 Meningioma Optic n. cavernous sinus 10.1 5 4
3 Meningioma Orbital apex 25.5 12
4 Meningioma Frontal & sphenoid bone 8.0 4 4
5 AVF* Ophthalmic a. 16.2 13
6 Cavernous hemangioma Orbital apex 31.5 15
7 Adenocystic ca. Lacrimal gland 26.2 13
8 Schwannoma Orbital apex 28.5 14
9 Meningioma Optic n, 10 5 4
10 Schwannoma Orbital apex 9.1 5 4

* AVF = arteriovenous fistula.

Table 2.
Summary of results after radiosurgery
No. of patients Pathologic diagnosis (months) Follow up Lesion Vol. (mm3)
Radiosurgical Visual Acuity
Before GKS* After GKS* response Before GKS* After GKS*
1 Meningioma 17 886.4 817.8 Necrosis 0.1 0.7
2 Meningioma 25 6800 4700 Shrunken LP(+) CF
3 Meningioma 13 2400 2074 Static 0.03 0.01
4 Meningioma 21 3100 8100 Aggravated 0.1 LP (−)
5 AVF* 16 32 25 Static 1.0 0.9
6 Cavernous hemangioma 18 2000 1400 Shrunken LP (−) LP (−)
7 Adenocystic ca. 3 2996.2 3879 Aggravated 1.0 Exenteration
8 Schwannoma 5 5000 4500 Static LP (+) LP (+)
9 Meningioma 9 736.6 733 Static 1.0 1.0
10 Schwannoma 12 1700 428 Shrunken 0.4 1.0

* GKS = gamma knife radiosurgery

LP= light perception

CF= counting fingers.

TOOLS
Similar articles